Back to Journals » OncoTargets and Therapy » Volume 16

Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion

Total article views   HTML views PDF downloads Totals
2,157 Dovepress* 2,066+ 79 2,145
PubMed Central* 91 49 140
Totals 2,157 128 2,285
*Since 7 July 2023

View citations on PubMed Central and Google Scholar